Shocked at the recent report published by prestigious University of Bristol on religion and ethnicity, Hindus have called on European Union to probe into the
Tag: EU
Actavis launches Gemcitabine on patent expiry in EU markets
The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone
